MENU
NRIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nurix Therapeutics (NRIX) Ownership - Who owns Nurix Therapeutics?
Profile
Industry
N/A
Address
1700 Owens Street
Phone
+1 415 660-5320
Employees
284
Web
http://www.nurixtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.5B
P/E Ratio
N/A
Total Cash
448.05M
Projected Growth
N/A
Total Debt
27.14M
Revenue
56.42M
Risk (Beta)
2.18
Dividend Yield
N/A
Total Cash/Share
6.33
Total Debt/Equity
N/A
Revenue/Share
0.92 USD as % of share price
Fundamentals
NRIX
Capitalization
1.5B
P/E Ratio
N/A
Risk (Beta)
2.18
Dividend Yield
N/A
Total Cash
448M
Total Cash/Share
6.33
Total Debt
27.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.92%
Revenue
56.4M
ROE
N/A
Book Value
377M
P/B Ratio
3.91
Cash Flow
N/A
Earnings
-2.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
67K
Current Ratio
5.28
Current Revenue Per Employee
44323.94
Dividends Per Share - Security
N/A
EBITDA
-177.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.07
Shares Held By Institutions
2.15B
Shares Outstanding - Current
70.8M
Total Liabilities
137M
Total Volume MTD
N/A
Value
N/A
Gain YTD
105.233
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1700 Owens Street
Phone
+1 415 660-5320
Employees
284
Web
http://www.nurixtx.com